Indicated for the treatment of frequent heartburn, Zegerid
OTC employs the dual action of omeprazole, a proton pump inhibitor that lowers the amount of acid in the stomach, and sodium bicarbonate, an antacid that raises the stomach's pH level to prevent the omeprazole from breaking down in stomach acid.
The company said Zegerid
OTC (omeprazole and sodium bicarbonate capsules, 20mg/1100mg) is indicated for the treatment of frequent heartburn.
For the most recent 12 months ending in May 2016, the Zegerid
brand and generic had US sales of approximately USD306.7m MAT, according to IMS Health.
Now, the company's product portfolio offers 22 marketed products, including XIFAXAN, UCERIS, GLUMETZA, APRISO, ZEGERID
, MOVIPREP, RELISTOR, SOLESTA, FULYZAQ, CYCLOSET and DEFLUX.
However, some people take PPIs (Prilosec, Prevacid, Zegerid
, Nexium) for months, and even years, without being evaluated for GERD, and recent research shows that many could stop taking PPIs and save a great deal of money if they underwent testing.
Two proton pump inhibitors, lansoprazole (Prevacid) and omeprazole (Prilosec, Zegerid
), are the antisecretory agents of choice for H.
Perrigo Co., for example, released lansoprazole capsules, a bio-equivalent to Novartis AG's Prevacid 24HR capsules, and omeprazole and sodium bicarbonate capsules, a generic version of Merck & Co's Zegerid
, in 2012.
According to Perrigo, its OTC version of Omeprazole and Sodium Bicarbonate Capsules is the store brand equivalent to Merck & Co's Zegerid
OTC, a proton pump inhibitor indicated to relieve frequent heartburn, which over the last 12 months recorded sales of about USD42m through food, drug and mass merchandisers.
(All PPI packaging will now carry a written warning.) This news is of particular concern for postmenopausal women who take a PPI such as Nexium, Prilosec, Zegerid
, or Aciphex, and are at risk of osteoporosis and fracture.
(+0.9%) Market Dollar sales Dollar sales LEADING BRANDS ** share (000) % change Private Label 40.4% $62,954 - 3.9% Prilosec OTC 16.1% 25,010 - 9.4% Zantac 150 6.8% 10,650 + 12.1% Prevacid 24HR 4.9% 7,564 - 7.3% Gas X 3.5% 5,488 + 0.9% Pepcid AC 3.2% 5,050 + 2.9% Tums 2.8% 4,327 - 13.8% Tums Ultra 2.3% 3,564 + 3.9% Pepcid Complete 2.2% 3,348 + 54.1% Zegerid
OTC 1.9% 3,017 - 3.4% TOTAL UNIT SALES * 58 mil.
The decrease in revenues resulted primarily from a decrease in net product sales of ZEGERID
brand products due to generic competition for ZEGERID
Capsules prescription products.
More recently, Novartis Consumer Healthcare Inc.'s Prevacid followed that path, as did Zegerid
from Merck & Co.